Glen Clack
- Oncology top 1%
- Bone health and treatments 8
- Cancer Cells and Metastasis 7
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 8
-
- Bone health and osteoporosis research 5
-
- Lung Cancer Treatments and Mutations 6
- Advanced Breast Cancer Therapies 6
- Genetics top 5%
- Estrogen and related hormone effects 16
-
- Chronic Myeloid Leukemia Treatments 6
Glen Clack
60 papers receiving 3.3k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 2.6k
- Cancer Research 1.3k
- Orthopedics and Sports Medicine 500
- Pulmonary and Respiratory Medicine 841
- Genetics 528
Countries citing papers authored by Glen Clack
This map shows the geographic impact of Glen Clack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen Clack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen Clack more than expected).
Fields of papers citing papers by Glen Clack
This network shows the impact of papers produced by Glen Clack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen Clack. The network helps show where Glen Clack may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Glen Clack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 71 | |
| 3 | 2021 | 7 | |
| 4 | 2021 | 4 | |
| 5 | 2017 | 1 | |
| 6 | 2014 | 38 | |
| 7 | 2013 | 3 | |
| 8 | 2012 | 7 | |
| 9 | 2012 | 107 | |
| 10 | 2012 | 21 | |
| 11 | 2011 | 343 | |
| 12 | 2011 | 371 | |
| 13 | 2011 | 208 | |
| 14 | 2010 | 36 | |
| 15 | 2008 | 306 | |
| 16 | 2008 | 23 | |
| 17 | 2007 | 15 | |
| 18 | Effect of an Aromatase Inhibitor on Bone Mineral Density and Bone Turnover Markers: 2 year Results of the 'Arimidex' (Anastrozole), Tamoxifen, Alone or in Combination (ATAC) trial | 2006 | 2 |
| 19 | 2004 | 9 | |
| 20 | 1999 | 16 |
About Glen Clack
Glen Clack is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 61 papers that have together received 3.3k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (16 papers), Cancer Genomics and Diagnostics (8 papers), Bone health and treatments (8 papers), Cancer Cells and Metastasis (7 papers), Lung Cancer Treatments and Mutations (6 papers), Advanced Breast Cancer Therapies (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Bone health and osteoporosis research (5 papers). The work is most often cited by research in Oncology (2.6k citations), Cancer Research (1.3k citations) and Orthopedics and Sports Medicine (500 citations). Glen Clack has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Caroline Dive, Andrew Hughes, Matthew Krebs, Richard Eastell, Fiona Blackhall, R.A. Hannon, Malcolm Ranson, Tim Ward, Lynsey Priest and Robert Szczepaniak‐Sloane. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Journal of Bone and Mineral Research and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.